Physician profile
Wen Long
NPI 1316064546
$12,268.86
in general payments reported to CMS, 2019-2025
12 companies · $520 in 2025
The $520 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,308 · 2020: $461 · 2021: $3,057 · 2022: $2,101 · 2023: $54.82 · 2024: $1,767 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,449 · Travel and Lodging: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,449.42 |
| Travel and Lodging | $892.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,984.41 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $1,903.65 | 2021-2025 | Phasix Mesh |
| Allergan, INC. | $775.20 | 2019-2022 | |
| Becton, Dickinson and Company | $175.72 | 2024 | Phasix Mesh |
| Hologic INC | $134.39 | 2019 | |
| Abiomed | $80.00 | 2022 | |
| Tela Bio, INC. | $76.66 | 2024 | Ovitex 2s |
| Hologic Sales and Service, LLC | $41.55 | 2025 | Magtrace |
| Cook Medical LLC | $27.21 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $26.13 | 2025 | |
| Biotronik INC. | $25.00 | 2019 | |
| Myriad Genetic Laboratories, INC. | $18.94 | 2024 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wen Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.